🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio

episode

The Biotech Startups Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

MIDWEEK RUB | Should Lachie Neale Get Off? Full Grand Final Preview + Brownlow Wrap 38 min · 23 Sep 2026 · Triple M Rocks Footy AFL

NPR News: 09-22-2026 9PM EDT 4 min · 23 Sep 2026 · NPR News Now

9PM ET 09/22/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

Stories from our Elders: My passionate friendship with a rebel poet 51 min · 23 Sep 2026 · Conversations

The forgotten nutrient every midlife woman needs – with Dr Craig Rose 41 min · 23 Sep 2026 · Age Better with Liz Earle

Bringing Kashmir’s lakes back to life 25 min · 23 Sep 2026 · The Documentary Podcast

Report any issue

Source

Recorded21 Nov 2024

Publisherfeeds.fame.so ↗

Handlerec:3386472

Show notes

Part 4 of 4: Jon Chee hosts Chris Moxham, Co-Founder, CEO, and CSO of Transcripta Bio—a pioneering biotech company accelerating drug discovery to improve lives worldwide. With a PhD in Molecular and Cellular Pharmacology from Stony Brook University and over 25 years in drug discovery, Chris brings a wealth of experience. During his two-decade tenure at Eli Lilly, he advanced over 10 molecules into clinical trials across multiple therapeutic areas, spanning both small and large molecule modalities. Chris’s deep expertise and dedication to scientific innovation and team development offer invaluable insights for aspiring biotech leaders.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in